With most stocks well off their 12-month highs, there are plenty of potential wins in the market the... Read More
Stifel GMP analyst Justin Keywood likes what he sees so far from Knight Therapeutics (Knight Therape... Read More
Specialty pharma company Knight Therapeutics (Knight Therapeutics Stock Quote, Chart, News TSX:GUD) ... Read More
All’s well with Knight Therapeutics (Knight Therapeutics Stock Quote, Chart, News TSX:GUD) after t... Read More
Knight Therapeutics (Knight Therapeutics Stock Quote, Chart, News TSX:GUD) is still in the early inn... Read More
The massive new acquisition of Grupo Biotoscana by Knight Therapeutics (Knight Therapeutics Stock Qu... Read More
Patience is a virtue, especially when it comes to specialty pharma name Knight Therapeutics (Knight ... Read More
It’s still early innings for Knight Therapeutics (Knight Therapeutics Stock Quote, Chart TSX:GUD),... Read More
In the ongoing fight for control of specialty pharma company Knight Therapeutics (Knight Therapeutic... Read More
Commercial-stage specialty pharma company Knight Therapeutics (Knight Therapeutics Stock Quote, Char... Read More
Specialty pharma company Knight Therapeutics (Knight Therapeutics Stock Quote, Chart TSX:GUD) has be... Read More
Specialty pharma company Knight Therapeutics (Knight Therapeutics Stock Quote, Chart TSX:GUD) has a ... Read More
Following the company’s second quarter results, Beacon Securities analyst David Kideckel has m... Read More
Specialty pharma stocks have been on the move lately, but Montreal-based Knight Therapeutics (TSX:GU... Read More
Investors looking for a solid opportunity in life sciences need look no further than Knight Therapeu... Read More
Even with the approval of its opioid dependence management drug, commercial-stage pharma company Kni... Read More
A new analyst covering Knight Therapeutics (Knight Therapeutics Stock Quote, Chart, News: TSX:GUD) a... Read More
Laurentian Bank Securities analyst Joseph Walewicz says investors have high expectations for the cas... Read More